Affiliation: Lund University
- Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancerAdalsteinn Gunnlaugsson
Department of Oncology, Lund University Hospital, Lund, Sweden
Acta Oncol 46:937-44. 2007..The aim of this study was to quantify the dose-volume relationship between irradiated bowel volumes and acute enteritis during combined chemoradiotherapy for rectal cancer...
- Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U studyAdalsteinn Gunnlaugsson
Department of Oncology, Lund University, Lund 22185, Sweden
Radiother Oncol 95:292-7. 2010....
- Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L StudyAdalsteinn Gunnlaugsson
Department of Oncology, Lund University Hospital, Lasarettsgatan, Lund, Sweden
Eur J Cancer 45:807-13. 2009..This study assessed radiotherapy combined with capecitabine and oxaliplatin in patients with primary, inextirpable colorectal adenocarcinoma...
- The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assayAdalsteinn Gunnlaugsson
Department of Oncology, Lund University Hospital, Lund Univeristy, Lund, Sweden
Radiat Oncol 4:61. 2009..The aim of this study was to investigate to what extent 5-FU and oxaliplatin influence the radiation (RT) induced small bowel mucosal damage when given in conjunction with single or split dose RT...